463-77-4

Usage

Uses

Used in Pharmaceutical and Pesticide Synthesis:
Carbamic acid is used as an intermediate in the synthesis of various pharmaceuticals and pesticides due to its ability to react with alcohols and amines to form carbamates.
Used in Herbicide Production:
Carbamic acid is used as a precursor to the herbicide carbaryl, which is an important commercial chemical in agriculture.
Used in Insecticide Synthesis:
Carbamic acid is used in the synthesis of various carbamate insecticides, which are widely used in pest control.
Used in the Production of Carbamates:
Carbamic acid is used to form carbamates, which are widely used in the production of pharmaceuticals, plastics, and other materials. These carbamates have various applications, including as active ingredients in pharmaceuticals and as components in the manufacturing of plastics and other materials.

InChI:InChI=1S/CH3NO2/c2-1(3)4/h2H2,(H,3,4)

Upstream product

• 420-05-3 cyanic acid 
• 873-50-7 3-Methyl-pyrazol-1-carbonsaeureamid 
• 124-38-9 carbon dioxide 
• 64-10-8 phenyl carbamate 
• 34773-66-5 1-(4-ethylphenyl)urea 
• 34773-65-4 1-(4-(dimethylamino)phenyl)urea 
• 622-51-5 p-tolylurea 
• 1967-27-7 (3-chlorophenyl)urea 
• 13142-61-5 (3-nitro-phenyl)-urea 
• 13114-87-9 N-(3-trifluoromethylphenyl)urea 
• 1566-42-3 p-anisidine urea 
• 135-92-2 N-(2-methoxyphenyl)urea 
• 154374-70-6 3-(3,4-dimethoxyphenyl)urea 
• 103860-38-4 2,5-dimethoxyphenylurea 

Downstream Products

• 169280-82-4 6-((tert-butoxycarbonyl)amino)nicotinic acid ethyl ester 
• 40217-37-6 Carbon Monoxide Hydrate 
• 651004-21-6 hydroxylamine*CO 
• 201230-82-2 carbon monoxide 
• 133531-30-3 methyl 4-((N-methyl-N-(3,4-dimethoxyphenylacetyl))amino)pentanoate 

Relevant academic research and scientific papers

VUV irradiation of carbon dioxide (CO2) and ammonia (NH3) complexes in argon matrix

In this study, we characterized by FTIR spectroscopy the 1:1 and 2:1 molecular complexes between NH3 and CO2 in argon matrix at low temperature. In addition we tentatively identified the 1:2 molecular complex. The structures of the c

N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity

The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.

Glucocorticoid receptor modulators

The present invention provides non-steroidal compounds of formula I which are selective modulators (i.e., agonists and antagonists) of a steroid receptor, specifically, the glucocorticoid receptor. The present invention also provides pharmaceutical compositions containing these compounds and methods for using these compounds to treat animals requiring glucocorticoid receptor agonist or antagonist therapy. Glucocorticoid receptor modulators are useful to treat diseases, such as obesity, diabetes, inflammation and others as described below. The present invention also provides intermediates and processes for preparing these compounds. STR1

α-and β-amino acid hydroxyethlamino sulfonamides useful as retroviral protease inhibitors

α- and β-amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.

Glucocorticoid receptor modulators

The present invention provides non-steroidal compounds of Formula I, and prodrugs and pharmaceutically acceptable salts thereof, which are selective modulators (e.g., agonists, partial agonists and antagonists) of a steroid receptor, specifically, the glucocorticoid receptor. The present invention also provides pharmaceutical compositions containing these compounds and methods for using these compounds to treat animals requiring glucocorticoid receptor agonist or antagonist therapy. Glucocorticoid receptor modulators are useful to treat diseases, such as obesity, diabetes, inflammation and others as described below. The present invention also provides processes for preparing these compounds.

Piperidine amides as modulators of chemo kine receptor activity

The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.

Phenylureas. Part 1. Mechanism of the basic hydrolysis of phenylureas

The mechanism of the hydrolytic decomposition of phenylureas in basic media in the pH range 12 to 14 is investigated. In this pH range a levelling of the rate-pH curve is observed as well as a change of the substituent influence on the hydrolysis rate. These experimental findings suggest the formation of an unreactive side product of the phenylurea in a parasitic side equilibrium at sufficiently high pH. The urea dissociates at the aryl-NH group to give its conjugate base. For the hydrolytic decomposition of phenylureas an addition-elimination mechanism is proposed as has been established for the alkaline hydrolysis of carboxylic acid esters and amides.

Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors

PCT No. PCT/US94/09139 Sec. 371 Date Jan. 24, 1996 Sec. 102(e) Date Jan. 24, 1996 PCT Filed Aug. 23, 1994 PCT Pub. No. WO95/06030 PCT Pub. Date Mar. 2, 1995The invention relates to sulfonamide-containing hydroxyethylamine protease inhibitor compounds, their process of making, composition and method of use for inhibiting retroviral proteases such as human immunodeficiency virus.

alpha - and beta -amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

alpha - and beta -amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.

Synthesis of benzo fused heterocyclic sulfonyl chlorides

A process for preparing a benzo fused heterocyclic sulfonyl halide comprising reacting a benzo fused heterocyclic compound with an SO3 complex in the presence of a water immiscible, non-reactive solvent, at a temperature of from about 0 DEG C. to about 75 DEG C., cooling, if necessary, to a temperature of from about -25 DEG C. to about 65 DEG C. and then adding oxalyl halide.